# Clinical Validation

> Medical deployment results and performance validation

---

## Deployment Overview

**Location**: Clinique Hartmann, Neuilly-sur-Seine (92), France  
**Department**: Intensive Care Unit (ICU)  
**Supervising Physician**: Dr. Lee  
**Duration**: 3 months continuous deployment  
**Period**: July - September 2024  

![PULSAR Clinical Prototypes](../images/prototypes/pulsar-dual-watches.jpg)
*PULSAR-007 and PULSAR-009 prototypes deployed in clinical validation*

---

## Validation Objectives

### Primary Goals

1. **Data Quality Verification**
   - Validate PPG signal quality against reference medical equipment
   - Confirm data integrity (zero loss requirement)
   - Assess motion artifact handling

2. **System Reliability**
   - Measure uptime during continuous operation
   - Evaluate battery life in real-world conditions
   - Test dual-mode architecture (WiFi/SD) reliability

3. **User Acceptance**
   - Patient comfort assessment
   - Medical staff workflow integration
   - Device durability under hospital conditions

4. **Safety Validation**
   - Biocompatibility of materials
   - Electrical safety compliance
   - Zero adverse event requirement

---

## Clinical Protocol

### Patient Demographics

| Metric | Value |
|--------|-------|
| **Total patients** | 50+ |
| **Age range** | 18-85 years |
| **Gender distribution** | Balanced cohort |
| **Medical conditions** | Diverse ICU pathologies |

### Data Collection Protocol

- **Session duration**: 5-minute recordings per session
- **Sessions per patient**: 24 recordings (distributed throughout hospitalization)
- **Total data volume**: 400+ hours of physiological signals
- **Recording frequency**: 100 Hz per channel (4 PPG channels + 3-axis accelerometer)

### Validation Methodology

```
Clinical Protocol Flow:

Patient Enrollment → Device Placement → Baseline Recording → Continuous Monitoring
                          ↓                     ↓                      ↓
                    Medical Staff         Reference Device      PULSAR Device
                    Training              (Gold Standard)       (Under Test)
                          ↓                     ↓                      ↓
                    ──────────────────────────────────────────────────────
                          ↓                                            ↓
                    Data Quality                              System Performance
                    Comparison                                Metrics Collection
```

---

## Results Summary

### System Performance Metrics

| Metric | Requirement | Result | Status |
|--------|-------------|--------|--------|
| **System Uptime** | ≥95% | 99.2% | ✅ Exceeded |
| **Data Loss** | 0% required | 0% measured | ✅ Achieved |
| **Battery Life (ESP32)** | 8h minimum | 8-10h typical | ✅ Met |
| **Device Failures** | <5% acceptable | 2/15 units (13%) | ⚠️ Minor issues |
| **Safety Incidents** | Zero tolerance | Zero incidents | ✅ Perfect |

### Data Quality Assessment

**Signal Quality Indicators:**
- ✅ PPG waveform morphology: Clinically interpretable
- ✅ Signal-to-noise ratio: Comparable to reference equipment
- ✅ Motion artifact rejection: Effective with accelerometer fusion
- ✅ Multi-spectral consistency: All 4 channels synchronized

![PPG Signal Quality](../images/architecture/ppg-waveform.png)
*Typical PPG signal showing clear cardiac features (systolic/diastolic peaks)*

![Spectral Analysis Validation](../images/architecture/ppg-spectral-analysis.png)
*Frequency domain analysis confirming cardiac band prominence (0.5-2 Hz)*

---

## User Feedback

### Patient Comfort

**Qualitative Assessment:**
- ✅ Lightweight and non-intrusive
- ✅ Suitable for extended wear (8+ hours)
- ✅ No skin irritation reported
- ⚠️ Occasional sensor displacement during vigorous movement (resolved with strap adjustment)

**Quantitative Metrics:**
- **Comfort rating**: 4.2/5.0 (patient survey)
- **Wear tolerance**: 95% completed full protocol without removal
- **Skin irritation**: 0% incidence

### Medical Staff Feedback

**Workflow Integration:**
- ✅ Simple device placement procedure (2-minute training)
- ✅ Clear LED status indicators
- ✅ Minimal maintenance required
- ✅ Compatible with hospital IT infrastructure

**Concerns Addressed:**
- Initial skepticism about device accuracy → **Resolved through side-by-side validation**
- Questions about data privacy → **AWS secure upload pipeline explained**
- Request for real-time display → **Added to future development roadmap**

---

## Technical Reliability

### Device Performance Distribution

| Prototype ID | Uptime | Issues Encountered |
|--------------|--------|--------------------|
| PULSAR-001 to PULSAR-013 | 99.5-100% | None |
| PULSAR-007 | 98.8% | Minor WiFi connectivity issue (resolved) |
| PULSAR-009 | 97.2% | SD card write error (hardware replacement) |

**Failure Analysis:**
- **WiFi intermittency** (1 unit): Environmental interference, solved with router repositioning
- **SD card error** (1 unit): Faulty microSD card, replaced during deployment

### Data Storage Validation

**Dual-Mode Architecture Performance:**

| Mode | Usage Percentage | Reliability |
|------|------------------|-------------|
| **WiFi + AWS** | 78% of sessions | 99.8% success rate |
| **Standalone SD** | 22% of sessions | 100% success rate |

**Key Finding**: Dual-mode architecture provided failsafe redundancy when hospital WiFi was unavailable.

---

## Regulatory Pathway Insights

### CE Marking Preparation

**Documentation Prepared:**
- ✅ Technical file (design history)
- ✅ Risk analysis (ISO 14971 methodology)
- ✅ Clinical evaluation report (preliminary)
- ✅ Biocompatibility testing results

**Next Steps:**
- 🔄 Expanded clinical trials (regulatory requirement)
- 🔄 EMC/EMI testing (electromagnetic compatibility)
- 🔄 IEC 60601-1 safety certification
- 🎯 Target: CE marking Q4 2025

### Regulatory Insights Gained

- **Data integrity is critical**: Zero data loss was non-negotiable for medical acceptance
- **Clinical validation scale**: 50+ patients is preliminary; regulatory approval requires larger cohorts (200-500+)
- **User training**: Medical devices must have foolproof interfaces (minimize training requirements)

---

## Lessons from Clinical Deployment

### Technical Learnings

1. **Battery life expectations**: 8-10h acceptable for ICU, but longer life needed for ambulatory care
2. **Sensor placement matters**: Deported circular sensor design was key to comfort and data quality
3. **Redundancy is essential**: Dual-mode (WiFi/SD) prevented data loss during network issues
4. **Real-time feedback**: Medical staff prefer immediate visual confirmation of signal quality

### Operational Learnings

1. **Hospital IT integration**: Each hospital has unique WiFi policies (standalone mode crucial)
2. **Device hygiene protocols**: Medical-grade silicone straps enable cleaning between patients
3. **Backup units essential**: Deployed 15 units to support 50+ patients (3:1 ratio necessary)
4. **Daily check-ins**: Regular device status reviews with medical staff improved deployment reliability

---

## Comparison with Reference Equipment

### Benchmarking Results

| Parameter | PULSAR | Reference Device | Delta |
|-----------|--------|------------------|-------|
| **Heart rate accuracy** | ±2 BPM | ±1 BPM (gold standard) | Within clinical tolerance ✅ |
| **Signal acquisition** | 100 Hz | 125 Hz | Sufficient for cardiac features ✅ |
| **Wearability** | Wristwatch form | Finger clip | Superior patient comfort ✅ |
| **Battery life** | 8-10h | AC-powered | Portable advantage ✅ |
| **Cost** | Prototype stage | €2,000-5,000 | Target: <€500 production |

**Key Takeaway**: PULSAR achieved near-reference accuracy with superior wearability and portability.

---

## Future Clinical Studies

### Planned Expansions

1. **Larger cohort validation** (regulatory requirement)
   - Target: 200-500 patients
   - Multi-center deployment
   - Diverse pathology groups

2. **Ambulatory monitoring studies**
   - Extended wear (24-72 hours)
   - Home monitoring scenarios
   - Chronic disease management

3. **Algorithm validation**
   - Automated heart rate extraction
   - Arrhythmia detection algorithms
   - SpO₂ estimation models

---

## Confidentiality Notice

Patient data, individual recordings, and detailed clinical protocols remain confidential per hospital ethics committee approval and GDPR compliance. This document provides aggregate results for portfolio demonstration purposes.

---

## Acknowledgments

Special thanks to:
- **Dr. Lee** (Clinique Hartmann) — Clinical supervision and validation protocol design
- **ICU Nursing Staff** — Daily device management and patient care coordination
- **Hospital Ethics Committee** — Protocol approval and patient safety oversight
- **Participating Patients** — Voluntary participation in medical device validation

---

**Related Documentation:**
- [System Architecture Overview](architecture.md)
- [Technical Challenges Solved](challenges.md)
- [Hardware Design Guide](../hardware/README.md)
